{"id":"W2515998798","doi":"10.1016/j.clinthera.2016.07.010","title":"Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study","year":2016,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline","keywords":"Mepolizumab; Medicine; Asthma; Term (time); Open label; Adverse effect; Internal medicine; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003027233,0.0002305384,0.0006864909,0.00007008869,0.00005530999,0.00001598977,0.0002254692,0.0001275441,0.00003367286],"category_scores_gemma":[0.0001098319,0.0001265271,0.00005332572,0.0001531353,0.0003562294,0.0001036157,0.0001867735,0.0001985656,0.000007515701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004080392,"about_ca_system_score_gemma":0.0001509678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003077457,"about_ca_topic_score_gemma":0.00001443475,"domain_scores_codex":[0.9979078,0.0002636995,0.0008451356,0.0004416501,0.0002762776,0.0002654914],"domain_scores_gemma":[0.9984712,0.0003635566,0.0002436435,0.0005159473,0.0001514359,0.0002542439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01115902,0.05692878,0.7010384,0.00002835657,0.0001668723,0.00003888368,0.00009856489,6.701931e-8,0.00003228839,0.00000316685,0.000005395939,0.2305002],"study_design_scores_gemma":[0.2159802,0.01139642,0.7714766,0.0003668017,0.0001374442,0.000004505105,0.00003515496,0.000007132763,0.00001634627,0.000003241438,0.0004281591,0.0001479908],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974188,0.0003109005,0.00007879456,0.000173639,0.00009622967,0.001799928,0.00006027925,0.00002218594,0.00003924533],"genre_scores_gemma":[0.9988793,0.0001726045,0.0001911732,0.0005315755,0.00005753157,0.00001477139,0.00001179481,0.00003659766,0.0001046662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2303522,"threshold_uncertainty_score":0.5159624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1029739026257499,"score_gpt":0.4248186128161392,"score_spread":0.3218447101903893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}